重组人生长激素真品的临床经验。

Clinical experience with authentic recombinant human growth hormone.

作者信息

Ranke M B

出版信息

Acta Paediatr Scand Suppl. 1986;325:90-2. doi: 10.1111/j.1651-2227.1986.tb10372.x.

DOI:10.1111/j.1651-2227.1986.tb10372.x

Abstract

Studies of authentic recombinant human growth hormone (rhGH) began very recently in Germany. In this study, one group of patients with hGH deficiency is naïve (no previous hGH treatment), and the second group has been treated with pituitary hGH. The mean age of diagnosis of 17 naïve patients so far accepted is about 8 years; patients who have previously received pituitary hGH are older and slightly taller. No other data are yet available for analysis.

摘要

对真正的重组人生长激素（rhGH）的研究最近才在德国开始。在这项研究中，一组生长激素缺乏症患者未曾接受过治疗（之前未接受过生长激素治疗），另一组则接受过垂体生长激素治疗。到目前为止接受研究的17名未接受过治疗的患者的平均诊断年龄约为8岁；之前接受过垂体生长激素治疗的患者年龄较大，身高略高。目前尚无其他数据可供分析。